Status:
COMPLETED
Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients
Lead Sponsor:
Bayer
Conditions:
Hypogonadism
Eligibility:
MALE
35-64 years
Brief Summary
With advancing age testosterone levels decline in men. Low testosterone levels plus certain symptoms are called "Late Onset Hypogonadism (LOH)". Adipose tissue may contribute to testosterone deficienc...
Eligibility Criteria
Inclusion
- Male patients \> 35yrs
- Waist Circumference \> 102cm
- Clinically and biochemically confirmed hypogonadism (testosterone group)
- Willingness to attempt weight optimization
Exclusion
- Androgen dependent carcinoma of the prostate or male mammary gland, past or present history of liver tumours
- hypersensitivity towards the active pharmaceutical ingredient or other ingredients.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00847314
Start Date
June 1 2007
End Date
October 1 2008
Last Update
June 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Germany